Datamonitor Healthcare provides market assessments and strategic insights into the global life sciences and biotechnology markets, as self-described.

Datamonitor Healthcare

Brandwatch is a social media suite company owned by Cision. It offers products such as Consumer Intelligence and Social Media Management, providing market research, consumer research, social media analytics, monitoring, and management services.

Giles Palmer

Ulrik Bo Larsen

Brandwatch

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

Clarivate Plc

FDB (First Databank) provides drug databases and medication decision support aimed at improving safety, efficiency, and outcomes in healthcare. The company offers integrated solutions relied upon by healthcare professionals and organizations.

Metric
Company Name	Datamonitor Healthcare	Brandwatch	Clarivate Plc	FDB (First Databank)
Symbol			CLVT
MSH ID	COM:DATAMONITORHEALTHCARE	COM:BRANDWATCH	COM:CLARIVATE	COM:FDBHEALTH
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Technology	Technology	Healthcare & Health Services
Industry	Healthcare Technology	Social Media Software	Information Technology Services	Pharmaceutical and Healthcare Technology
Country	US	GB	GB	US
Stage		Venture Round	Post-IPO Equity
Employee Count		1.13K	12K
Website	datamonitorhealthcare.com	brandwatch.com	clarivate.com	fdbhealth.com
LinkedIn		brandwatch	clarivate
Founders

Metric
Market Cap		3.97B
Enterprise Value
Monthly Web Traffic	616.81K	4.77M
Web Traffic Growth	-0.17	0.12
Valuation
Raised Capital		94M

Metric
Revenue			2.63B
Revenue (LTM)
Revenue (NTM)
Gross Profit			1.01B
EBITDA			982.70M
Operating Income			274.40M
Net Income			-911.20M
EPS			-1.36
Diluted EPS			-1.36
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.59
Operating Profit Margin			0.10
EBITDA Margin			0.37
Net Profit Margin			-0.35
Return on Equity			-0.14
Return on Assets			-0.07
Return on Capital Employed			0.02

COM:DATAMONITORHEALTHCARE

Datamonitor Healthcare

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-31.73
P/B Ratio			0.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			1.94
EV Multiple			0.75

Metric
Days Sales Outstanding			107.09
Days Payables Outstanding			40.29
Days Inventory Outstanding			46.92
Operating Cycle			161.53
Cash Conversion Cycle			126.65
Asset Turnover			0.22

Metric
Operating Cash Flow			744.20M
Free Cash Flow			501.70M
Cash Flow to Debt			0.16
Operating Cash Flow/Sales			0.28
Free Cash Flow Yield			0.08

Metric
Cash & Equivalents			370.70M
Accounts Receivable			-25.50M
Inventory
Goodwill			2.02B
Debt to Capitalization			0.46
Debt to Assets			0.37
Current Ratio			0.94
Quick Ratio			0.90

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.05
R&D to Revenue
SG&A to Revenue